Biogen drug against Alzheimer's enters advanced phase of trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters biogen plans to advance an experimental Alzheimer's disease drug into…
biogen inc
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
Novo Nordisk shares fall after Alzheimer's drug trial falls short of target
A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, outside Copenhagen, Denmark, July 14, 2025.…
Novartis, Roche could be at greater risk
The medications are stored on shelves on a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer |…
FDA TAPS Executive Biotechnology George Tidmarsh as the main drug regulator in RFK Jr.
File photo: The headquarters of the United States Drug and Food Administration (FDA) is seen in Silver Spring, Maryland, November…
Trump tariffs will challenge the big pharmaceuticals. Here are well positioned actions
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
Biogen profits (BIIB) Q4 2024
A test tube is observed in front of the biogen logo shown in this illustration taken on December 1, 2021.…
Anti-schizophrenia drug Cobenfy could treat Alzheimer's
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…
Innovative biotech stocks have a good chance of breaking out in 2025
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…
Biogen (BIIB) Third Quarter 2024 Earnings
A test tube is seen in front of the Biogen logo in this illustration taken on December 1, 2021. Ruvic…